Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NBY
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in NovaBay Pharmaceuticals, Inc stock price on Wednesday moving 28.16% between high and low
(Updated on Mar 27, 2024)

Sell candidate since Mar 27, 2024 PDF

The NovaBay Pharmaceuticals, Inc stock price fell by -19.99% on the last day (Wednesday, 27th Mar 2024) from $0.139 to $0.111. During the last trading day the stock fluctuated 28.16% from a day low at $0.101 to a day high of $0.130. The price has fallen in 6 of the last 10 days and is down by -21.45% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 8 million shares were bought and sold for approximately $838.61 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.104 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -26.60% during the next 3 months and, with a 90% probability hold a price between $0.0761 and $0.105 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NBY Signals & Forecast

There are few to no technical positive signals at the moment. The NovaBay Pharmaceuticals, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.133 and $0.144. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, February 16, 2024, and so far it has fallen -32.86%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for NovaBay Pharmaceuticals, Inc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0285 between high and low, or 28.16%. For the last week the stock has had daily average volatility of 12.19%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NBY) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect NovaBay Pharmaceuticals, Inc to open at $0.114, and during the day (based on 14 day Average True Range), to move between $0.0975 and $0.125, which gives a possible trading interval of +/-$0.0137 (+/-12.33%) up or down from last closing price. If NovaBay Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 24.66% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.133, some $0.0221 (19.85%) from the current price of $0.111, our system finds the risk reward not very attractive.

Is NovaBay Pharmaceuticals, Inc stock A Buy?

NovaBay Pharmaceuticals, Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Strong Sell candidate.

Current score: -8.326 Strong Sell Candidate Downgraded

Predicted Opening Price for NovaBay Pharmaceuticals, Inc of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.114 ( 2.54%) $0.111

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NBY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.143 28.16 %
R2 0.132 18.37 %
R1 0.125 12.32 %
Current price: 0.111
Support S1 0.103 -7.25 %
S2 0.0964 -13.30 %
S3 0.0855 -23.09 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.139 24.98 %
R2 0.135 21.11 %
R1 0.133 19.85 %
Current price 0.111
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for NovaBay Pharmaceuticals, Inc Stock and on which exchange is it traded?
The symbol for NovaBay Pharmaceuticals, Inc is NBY and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell NovaBay Pharmaceuticals, Inc Stock?
NovaBay Pharmaceuticals, Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Strong Sell candidate.

How to buy NovaBay Pharmaceuticals, Inc Stock?
NovaBay Pharmaceuticals, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NovaBay Pharmaceuticals, Inc Stock.

What's the current price of NovaBay Pharmaceuticals, Inc Stock?
As of the end of day on the 2024-03-27, the price of an NovaBay Pharmaceuticals, Inc (NBY) share was $0.111.

What is the 52-week high and low for NovaBay Pharmaceuticals, Inc Stock?
The 52-week high for NovaBay Pharmaceuticals, Inc Stock is $1.95 and the 52-week low is $0.101.

What is the market capitalization of NovaBay Pharmaceuticals, Inc Stock?
As of the 2024-03-27, the market capitalization of NovaBay Pharmaceuticals, Inc is 4.184M.

When is the next earnings date for NovaBay Pharmaceuticals, Inc?
The upcoming earnings date for NovaBay Pharmaceuticals, Inc is Apr 04, 2024.
Click to get the best stock tips daily for free!

About NovaBay Pharmaceuticals, Inc

NovaBay Pharmaceuticals NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising ... NBY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT